- Home
- UBCP vs IGMS Comparison
UBCP vs IGMS Comparison
Compare UBCP & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBCP
- IGMS
- Stock Information
- Founded
- UBCP 1902
- IGMS 1993
- Country
- UBCP United States
- IGMS United States
- Employees
- UBCP N/A
- IGMS N/A
- Industry
- UBCP Major Banks
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- UBCP Finance
- IGMS Health Care
- Exchange
- UBCP Nasdaq
- IGMS Nasdaq
- Market Cap
- UBCP 76.2M
- IGMS 82.1M
- IPO Year
- UBCP N/A
- IGMS 2019
- Fundamental
- Price
- UBCP $13.88
- IGMS $1.27
- Analyst Decision
- UBCP
- IGMS Hold
- Analyst Count
- UBCP 0
- IGMS 8
- Target Price
- UBCP N/A
- IGMS $6.14
- AVG Volume (30 Days)
- UBCP 3.3K
- IGMS 173.6K
- Earning Date
- UBCP 05-09-2025
- IGMS 05-13-2025
- Dividend Yield
- UBCP 6.48%
- IGMS N/A
- EPS Growth
- UBCP N/A
- IGMS N/A
- EPS
- UBCP 1.24
- IGMS N/A
- Revenue
- UBCP $29,412,000.00
- IGMS $2,681,000.00
- Revenue This Year
- UBCP N/A
- IGMS $124.45
- Revenue Next Year
- UBCP $5.59
- IGMS $45.07
- P/E Ratio
- UBCP $11.19
- IGMS N/A
- Revenue Growth
- UBCP N/A
- IGMS 27.36
- 52 Week Low
- UBCP $11.40
- IGMS $0.92
- 52 Week High
- UBCP $14.78
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- UBCP 70.84
- IGMS 52.80
- Support Level
- UBCP $13.59
- IGMS $1.13
- Resistance Level
- UBCP $13.74
- IGMS $1.42
- Average True Range (ATR)
- UBCP 0.33
- IGMS 0.09
- MACD
- UBCP 0.12
- IGMS 0.01
- Stochastic Oscillator
- UBCP 100.00
- IGMS 55.88
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.